All articles tagged: Attention-deficit hyperactivity disorder, predominantly inattentive type (F90.0)


HealthDay 25 June at 03.04 PM ADHD Meds May Help Control Opioid Use Disorder in Pregnancy Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental Health.Kevin Y. Xu, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benef # Psychiatry # Pharmacy # Family Practice # OBGYN & Women's Health 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 30 January at 11.19 PM Mislabeled Bottles Trigger Recall of the ADHD Drug Zenzedi One lot of Zenzedi (dextroamphetamine sulfate) 30-mg tablets is being recalled after a pharmacist found antihistamine tablets (carbinoxamine) in a bottle labeled as Zenzedi, according to a recall notice issued by Azurity Pharmaceuticals Inc.The recall comes amid an <a href="https://www.healthday.com/healthpro-news/child-health/amid-shortages-fe # Psychiatry # Pharmacy # Neurology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 22 January at 04.50 PM Sleep Disorders Differ for Autism, ADHD Versus Typical Development For most types of sleep disorders, there are significant differences for children with autism spectrum disorder (ASD) and those with attention-deficit/hyperactivity disorder (ADHD) compared with typically developing (TD) children, according to a study published online Dec. 29 in Autism Research.Carmen Berenguer, Ph.D., from the Universi # Psychiatry # Pediatrics # Family Practice # Neurology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 17 January at 11.52 PM New Rx for Schedule-II Stimulants for ADHD Increased During Pandemic Incident use of common behavioral health medications remained relatively stable during the COVID-19 pandemic, with the exception of those for attention-deficit/hyperactivity disorder (ADHD), according to a study published online Jan. 10 in JAMA Psychiatry.Grace Chai, Pharm.D., M.P.H., from the U.S. Food and Drug Administration i # Psychiatry # Internal Medicine # Pharmacy # Family Practice 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 30 November at 09.59 PM Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD The presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online Nov. 30 in JAMA Network Open.Soo Min Jeon, Pharm.D., Ph.D., from Jeju National University in South Korea, and # Psychiatry 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 29 November at 10.47 PM Before ADHD Diagnosis, Youth Twice as Likely to Have Used Health Care Services Two years before attention-deficit/hyperactivity disorder (ADHD) diagnosis, youth with ADHD are twice as likely to use health care services as youth without the condition, according to a study published online Oct. 30 in the Archives of Disease in Childhood.Vibhore Prasad, Ph.D., from King's College London, and colleagues used p # Psychiatry # Pediatrics # Family Practice # Neurology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 27 November at 05.03 PM Long-Term Exposure to ADHD Meds Linked to Increased Risk for CVD Long-term exposure to attention-deficit/hyperactivity disorder (ADHD) medications is associated with an increased risk for cardiovascular disease (CVD), especially hypertension, according to a study published online Nov. 22 in JAMA Psychiatry.Le Zhang, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the assoc # Psychiatry # Cardiology # Pediatrics # Internal Medicine 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


Medpage Today 17 November at 10.31 PM Two Treatments That Don't Work for Osteoarthritis WASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 11 November at 07.56 AM Scoring System Could Mean Better Access to Lung Transplant Scoring system could improve access for hard-to-match candidates due to height and blood type. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 07 November at 07.50 AM How key results could influence health policy The results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 05 November at 07.00 PM Mpox Cases in Congo May Be Stabilizing GOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 02 November at 07.40 AM Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study finds Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 31 October at 06.30 AM Report: Rethink Race-Based Adjustments in Clinical Tools The slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medpage Today 25 October at 02.09 PM Patients More Satisfied With AI's Answers Than Those From Their Doctor Patients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 25 October at 12.40 PM Surgical innovation: The intelligent turbine insufflator The Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 24 October at 07.50 AM Genetic variants in melatonin receptor linked to idiopathic osteoporosis Columbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 23 October at 10.58 PM Risk for Psychiatric Disorders Up for Offspring of Moms With Eating Disorder Offspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders, according to a study published online Oct. 22 in JAMA Network Open.Ida A.K. Nilsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a popula 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn